US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GRAIL, Inc.

76.58

-2.9600-3.72%

Post-market: 76.00-0.5800-0.76%17:45 EDT

Volume:380.93K

Turnover:29.43M

Market Cap:3.42B

PE:-7.86

High:81.87

Open:81.87

Low:75.61

Close:79.54

52wk High:118.84

52wk Low:30.82

Shares:44.67M

Float Shares:40.64M

Volume Ratio:0.44

T/O Rate:0.94%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-9.7487

EPS(LYR):-11.1105

ROE:-16.12%

ROA:-12.03%

PB:1.35

PE(LYR):-6.89

Loading ...

Overview Company News Filings

GRAIL (GRAL) Is Down 6.5% After FDA Sets Galleri PMA Panel Review – Has The Bull Case Changed?

Simply Wall St.

GRAIL (GRAL) Could Be 5% Overvalued As FDA Review Date Sharpens Focus

Simply Wall St.

GRAIL Says FDA Advisory Committee to Review GRAIL Galleri PMA Application on September 23

US FDA to Hold Advisory Meeting to Review Grail's Multi-Cancer Test

Grail announces FDA advisory committee meeting to review Galleri test PMA

Grail Says FDA Advisory Panel Meets Sept. 23 on Galleri Test PMA Review

Grail Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test

THOMSON REUTERS

Analysts Offer Insights on NA Companies: GRAIL Inc (GRAL) and Lineage, Inc. (LINE)

Analysts Offer Insights on NA Companies: GRAIL Inc (GRAL) and SanDisk Corp (SNDK)

Grail Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

GRAIL Q2 EPS $(2.56) Beats $(2.62) Estimate, Sales $44.687M Beat $42.760M Estimate

Benzinga Earnings

Grail Q2 Revenue Rises 26%, Net Loss Narrows 3%

Grail Inc Q2 Net Income USD -110.247 Million

THOMSON REUTERS

Grail Inc Expected to Post a Loss of $2.65 a Share - Earnings Preview

Grail Management to Present at Canaccord Genuity Growth Conference

Grail to Report Q2 2026 Results After Market Close, Host Webcast Call

Priority Health Collaborates with Grail as the First Michigan Health Plan to Offer the Galleri® Multi-cancer Early Detection Blood Test to Employer Plans

THOMSON REUTERS

Grail Inc : Mizuho Raises Target Price to $65 from $58

THOMSON REUTERS

Cancer Blood Screen Spac's Merger is Delayed by Test's Results

GRAIL (GRAL) Could Be 5% Overvalued Following Trial Miss And Class Actions

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/GRAL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GRAL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRAL\",,,,,undefined,":{"symbol":"GRAL","market":"US","secType":"STK","nameCN":"GRAIL, Inc.","latestPrice":76.58,"timestamp":1787601600000,"preClose":79.54,"halted":0,"volume":380927,"hourTrading":{"tag":"盘后","latestPrice":76,"preClose":76.58,"latestTime":"17:45 EDT","volume":12777,"amount":978444.5166600001,"timestamp":1787607959577,"change":-0.58,"changeRate":-0.007574,"amplitude":0.024811},"delay":0,"changeRate":-0.03721398038722665,"floatShares":40644723,"shares":44666200,"eps":-9.748709,"marketStatus":"Post-Mkt","change":-2.96,"latestTime":"08-24 18:15:39 EDT","open":81.87,"high":81.87,"low":75.6101,"amount":29433542.097692,"amplitude":0.078701,"askPrice":77,"askSize":40,"bidPrice":75.51,"bidSize":315,"shortable":3,"etf":0,"ttmEps":-9.748709,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":79.54,"preHourTrading":{"tag":"盘前","latestPrice":81.46,"preClose":79.54,"latestTime":"09:28 EDT","volume":9936,"amount":807381.4155840001,"timestamp":1787578080154,"change":1.92,"changeRate":0.024139,"amplitude":0.030488},"postHourTrading":{"tag":"盘后","latestPrice":76,"preClose":76.58,"latestTime":"17:45 EDT","volume":12777,"amount":978444.5166600001,"timestamp":1787607959577,"change":-0.58,"changeRate":-0.007574,"amplitude":0.024811},"volumeRatio":0.436582,"impliedVol":0.8668,"impliedVolPercentile":0.2829},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRAL\",,,,,undefined,":{"symbol":"GRAL","floatShares":40644723,"roa":"-12.03%","roe":"-16.12%","lyrEps":-11.110457,"volumeRatio":0.436582,"shares":44666200,"dividePrice":0,"high":81.87,"amplitude":0.078701,"preClose":79.54,"low":75.6101,"week52Low":30.82,"pbRate":"1.35","psRate":"20.70","week52High":118.84,"institutionHeld":0,"latestPrice":76.58,"committee":0.774648,"eps":-9.748709,"divideRate":0,"volume":380927,"delay":0,"ttmEps":-9.748709,"open":81.87,"prevYearClose":85.59,"prevWeekClose":79.54,"prevMonthClose":68.56,"prevQuarterClose":68.27,"fiveDayClose":69.95,"twentyDayClose":66.77,"sixtyDayClose":73.92},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GRAL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"GRAL","fiscalQuarterEnding":"2026/06","expectedEps":-2.91,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":-2.56},{"market":"US","date":"2026-05-05","symbol":"GRAL","fiscalQuarterEnding":"2026/03","expectedEps":3,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"post","actualEps":-2.29},{"market":"US","date":"2026-02-19","symbol":"GRAL","fiscalQuarterEnding":"2025/12","expectedEps":-3.33,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771477200000,"reportTimeType":"post","actualEps":-1.86},{"market":"US","date":"2025-11-12","symbol":"GRAL","fiscalQuarterEnding":"2025/09","expectedEps":-3.4,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-2.46},{"market":"US","date":"2025-08-12","symbol":"GRAL","fiscalQuarterEnding":"2025/06","expectedEps":-3.14,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-3.18}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GRAL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GRAL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2222,"buy":0.2222,"hold":0.5556,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2222,"analysts":9,"updateTime":1780718400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GRAL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GRAL","date":"2026-08-21","current":-7.916659,"percent":0.089695,"low":-11.136928,"twenty":-7.372329,"median":-0.87796,"eighty":-0.295699,"high":-0.135365,"avg":-3.501538,"sd":3.477318,"marketCap":3482626264},"quantilePoints":[{"date":"2024-06-12","current":-0.243184,"twenty":-0.243184,"median":-0.243184,"eighty":-0.243184,"marketCap":362571424},{"date":"2024-06-28","current":-0.269888,"twenty":-0.264547,"median":-0.256536,"eighty":-0.248525,"marketCap":402385270},{"date":"2024-07-05","current":-0.275763,"twenty":-0.275763,"median":-0.271757,"eighty":-0.266328,"marketCap":411144316},{"date":"2024-07-12","current":-0.259385,"twenty":-0.273627,"median":-0.266328,"eighty":-0.249504,"marketCap":386725157},{"date":"2024-07-15","current":-0.263657,"twenty":-0.273022,"median":-0.264992,"eighty":-0.25148,"marketCap":393095372},{"date":"2024-08-02","current":-0.296236,"twenty":-0.274909,"median":-0.266328,"eighty":-0.253456,"marketCap":441668264},{"date":"2024-08-09","current":-0.310656,"twenty":-0.300615,"median":-0.272114,"eighty":-0.260667,"marketCap":463167741},{"date":"2024-08-16","current":-0.170902,"twenty":-0.29588,"median":-0.2706,"eighty":-0.248276,"marketCap":492749978},{"date":"2024-08-23","current":-0.178117,"twenty":-0.292284,"median":-0.264992,"eighty":-0.180551,"marketCap":513552907},{"date":"2024-08-30","current":-0.159595,"twenty":-0.28292,"median":-0.259385,"eighty":-0.170708,"marketCap":460148373},{"date":"2024-09-06","current":-0.145057,"twenty":-0.275763,"median":-0.247457,"eighty":-0.162201,"marketCap":418232023},{"date":"2024-09-13","current":-0.145918,"twenty":-0.275336,"median":-0.18151,"eighty":-0.152854,"marketCap":420715955},{"date":"2024-09-20","current":-0.149365,"twenty":-0.273627,"median":-0.178117,"eighty":-0.150075,"marketCap":430651682},{"date":"2024-09-27","current":-0.146457,"twenty":-0.273022,"median":-0.170741,"eighty":-0.146026,"marketCap":422268412},{"date":"2024-10-04","current":-0.135365,"twenty":-0.270458,"median":-0.165733,"eighty":-0.14454,"marketCap":390287790},{"date":"2024-10-11","current":-0.140319,"twenty":-0.269176,"median":-0.160133,"eighty":-0.142925,"marketCap":404570398},{"date":"2024-10-18","current":-0.152918,"twenty":-0.265794,"median":-0.156041,"eighty":-0.143463,"marketCap":440897901},{"date":"2024-10-25","current":-0.13978,"twenty":-0.263443,"median":-0.155556,"eighty":-0.143463,"marketCap":403017941},{"date":"2024-10-31","current":-0.146672,"twenty":-0.262589,"median":-0.153942,"eighty":-0.142688,"marketCap":422889395},{"date":"2024-11-08","current":-0.160456,"twenty":-0.259385,"median":-0.152918,"eighty":-0.142796,"marketCap":462632305},{"date":"2024-11-15","current":-0.250879,"twenty":-0.250879,"median":-0.154641,"eighty":-0.143442,"marketCap":531228205},{"date":"2024-11-22","current":-0.259924,"twenty":-0.250879,"median":-0.156041,"eighty":-0.143549,"marketCap":550380645},{"date":"2024-11-29","current":-0.277697,"twenty":-0.262044,"median":-0.156472,"eighty":-0.143635,"marketCap":588013510},{"date":"2024-12-06","current":-0.355611,"twenty":-0.27003,"median":-0.160025,"eighty":-0.14426,"marketCap":752993300},{"date":"2024-12-13","current":-0.329745,"twenty":-0.275763,"median":-0.161318,"eighty":-0.144928,"marketCap":698224042},{"date":"2024-12-20","current":-0.271984,"twenty":-0.27776,"median":-0.165841,"eighty":-0.145746,"marketCap":575917232},{"date":"2024-12-27","current":-0.308005,"twenty":-0.287312,"median":-0.170741,"eighty":-0.145918,"marketCap":652190984},{"date":"2025-01-03","current":-0.284362,"twenty":-0.289787,"median":-0.175532,"eighty":-0.146134,"marketCap":602125834},{"date":"2025-01-10","current":-0.280236,"twenty":-0.294514,"median":-0.180594,"eighty":-0.1465,"marketCap":593389633},{"date":"2025-01-17","current":-0.276189,"twenty":-0.293978,"median":-0.222157,"eighty":-0.146801,"marketCap":584821436},{"date":"2025-01-24","current":-0.412102,"twenty":-0.295346,"median":-0.234852,"eighty":-0.147318,"marketCap":872612048},{"date":"2025-01-31","current":-0.500013,"twenty":-0.298484,"median":-0.241319,"eighty":-0.14818,"marketCap":1058760325},{"date":"2025-02-07","current":-0.523498,"twenty":-0.307212,"median":-0.249504,"eighty":-0.148826,"marketCap":1108489468},{"date":"2025-02-14","current":-0.83436,"twenty":-0.31102,"median":-0.255132,"eighty":-0.149365,"marketCap":1766728591},{"date":"2025-02-21","current":-0.791697,"twenty":-0.321747,"median":-0.260916,"eighty":-0.149365,"marketCap":1604772870},{"date":"2025-02-28","current":-0.656882,"twenty":-0.34371,"median":-0.263657,"eighty":-0.149709,"marketCap":1331502572},{"date":"2025-03-07","current":-0.559345,"twenty":-0.359577,"median":-0.270244,"eighty":-0.149795,"marketCap":1133795978},{"date":"2025-03-14","current":-0.450152,"twenty":-0.414561,"median":-0.273627,"eighty":-0.15014,"marketCap":912460022},{"date":"2025-03-21","current":-0.465034,"twenty":-0.450921,"median":-0.275763,"eighty":-0.150484,"marketCap":942626791},{"date":"2025-03-28","current":-0.47791,"twenty":-0.468947,"median":-0.276427,"eighty":-0.150807,"marketCap":968726130},{"date":"2025-04-04","current":-0.416039,"twenty":-0.465703,"median":-0.277856,"eighty":-0.15113,"marketCap":843313720},{"date":"2025-04-11","current":-0.380338,"twenty":-0.459122,"median":-0.280236,"eighty":-0.151281,"marketCap":770947370},{"date":"2025-04-17","current":-0.443129,"twenty":-0.455455,"median":-0.281347,"eighty":-0.151562,"marketCap":898224019},{"date":"2025-04-25","current":-0.630246,"twenty":-0.466372,"median":-0.283965,"eighty":-0.151863,"marketCap":1277511821},{"date":"2025-05-02","current":-0.565758,"twenty":-0.478944,"median":-0.287218,"eighty":-0.15253,"marketCap":1146794916},{"date":"2025-05-09","current":-0.62862,"twenty":-0.498389,"median":-0.292296,"eighty":-0.15337,"marketCap":1274216573},{"date":"2025-05-16","current":-0.732698,"twenty":-0.51302,"median":-0.295346,"eighty":-0.153995,"marketCap":1402606531},{"date":"2025-05-23","current":-0.728564,"twenty":-0.527433,"median":-0.296725,"eighty":-0.154728,"marketCap":1394692362},{"date":"2025-05-30","current":-0.772349,"twenty":-0.542338,"median":-0.298484,"eighty":-0.155417,"marketCap":1478510603},{"date":"2025-06-06","current":-0.742094,"twenty":-0.562722,"median":-0.305137,"eighty":-0.155977,"marketCap":1420593278},{"date":"2025-06-13","current":-0.787758,"twenty":-0.602918,"median":-0.308322,"eighty":-0.156041,"marketCap":1508008868},{"date":"2025-06-20","current":-0.910282,"twenty":-0.617043,"median":-0.310838,"eighty":-0.156127,"marketCap":1742556049},{"date":"2025-06-27","current":-0.927946,"twenty":-0.628237,"median":-0.313683,"eighty":-0.156967,"marketCap":1776371133},{"date":"2025-07-03","current":-0.87796,"twenty":-0.640897,"median":-0.324667,"eighty":-0.158949,"marketCap":1680681639},{"date":"2025-07-11","current":-0.815382,"twenty":-0.656882,"median":-0.33641,"eighty":-0.159595,"marketCap":1560889904},{"date":"2025-07-18","current":-0.675007,"twenty":-0.694504,"median":-0.351643,"eighty":-0.160456,"marketCap":1292167904},{"date":"2025-07-25","current":-0.746416,"twenty":-0.703946,"median":-0.35847,"eighty":-0.160672,"marketCap":1428867181},{"date":"2025-08-01","current":-0.642872,"twenty":-0.704698,"median":-0.372061,"eighty":-0.161318,"marketCap":1230653229},{"date":"2025-08-08","current":-0.619382,"twenty":-0.703946,"median":-0.384644,"eighty":-0.164764,"marketCap":1185686362},{"date":"2025-08-15","current":-2.618835,"twenty":-0.718416,"median":-0.412102,"eighty":-0.165733,"marketCap":1160018171},{"date":"2025-08-22","current":-2.697774,"twenty":-0.721799,"median":-0.415789,"eighty":-0.165949,"marketCap":1194984536},{"date":"2025-08-29","current":-2.7759,"twenty":-0.732698,"median":-0.419718,"eighty":-0.170579,"marketCap":1229590423},{"date":"2025-09-05","current":-2.733582,"twenty":-0.742958,"median":-0.427076,"eighty":-0.170837,"marketCap":1210845568},{"date":"2025-09-12","current":-3.145369,"twenty":-0.751941,"median":-0.435395,"eighty":-0.172539,"marketCap":1393247431},{"date":"2025-09-19","current":-3.221867,"twenty":-0.757193,"median":-0.443129,"eighty":-0.177083,"marketCap":1427132362},{"date":"2025-09-26","current":-3.927439,"twenty":-0.772199,"median":-0.450236,"eighty":-0.179927,"marketCap":1739666779},{"date":"2025-10-03","current":-5.267781,"twenty":-0.790326,"median":-0.453995,"eighty":-0.180724,"marketCap":2333374029},{"date":"2025-10-10","current":-5.788618,"twenty":-0.792794,"median":-0.466707,"eighty":-0.18193,"marketCap":2564079942},{"date":"2025-10-17","current":-7.032117,"twenty":-0.810572,"median":-0.474733,"eighty":-0.214168,"marketCap":3114890311},{"date":"2025-10-24","current":-6.726125,"twenty":-0.834423,"median":-0.483801,"eighty":-0.232186,"marketCap":2979350587},{"date":"2025-10-31","current":-7.417862,"twenty":-0.86879,"median":-0.497307,"eighty":-0.23482,"marketCap":3285756878},{"date":"2025-11-07","current":-6.515349,"twenty":-0.90953,"median":-0.508594,"eighty":-0.23627,"marketCap":2885986787},{"date":"2025-11-14","current":-7.32206,"twenty":-1.284423,"median":-0.515869,"eighty":-0.238888,"marketCap":3243320953},{"date":"2025-11-21","current":-8.218834,"twenty":-2.622741,"median":-0.524768,"eighty":-0.242438,"marketCap":3338827399},{"date":"2025-11-28","current":-10.592844,"twenty":-2.668803,"median":-0.533066,"eighty":-0.245748,"marketCap":4303247596},{"date":"2025-12-05","current":-10.047321,"twenty":-2.733908,"median":-0.545714,"eighty":-0.248685,"marketCap":4081633659},{"date":"2025-12-12","current":-9.121802,"twenty":-2.773947,"median":-0.559678,"eighty":-0.249586,"marketCap":3705650118},{"date":"2025-12-19","current":-8.474563,"twenty":-3.023948,"median":-0.565758,"eighty":-0.250383,"marketCap":3442715024},{"date":"2025-12-26","current":-8.814736,"twenty":-3.115583,"median":-0.600672,"eighty":-0.254281,"marketCap":3580907004},{"date":"2026-01-02","current":-8.213077,"twenty":-3.191837,"median":-0.607471,"eighty":-0.259493,"marketCap":3336488466},{"date":"2026-01-09","current":-9.407758,"twenty":-3.756539,"median":-0.615248,"eighty":-0.260321,"marketCap":3821817142},{"date":"2026-01-16","current":-9.350183,"twenty":-4.63773,"median":-0.618067,"eighty":-0.262044,"marketCap":3798427809},{"date":"2026-01-23","current":-11.136928,"twenty":-5.050494,"median":-0.621638,"eighty":-0.262589,"marketCap":4524276801},{"date":"2026-01-30","current":-9.689876,"twenty":-5.381714,"median":-0.623725,"eighty":-0.263657,"marketCap":3936424878},{"date":"2026-02-06","current":-9.025844,"twenty":-5.92371,"median":-0.62862,"eighty":-0.266328,"marketCap":3666667895},{"date":"2026-02-13","current":-9.201448,"twenty":-6.490935,"median":-0.634416,"eighty":-0.269888,"marketCap":3738005363},{"date":"2026-02-20","current":-10.027753,"twenty":-6.738169,"median":-0.640672,"eighty":-0.270458,"marketCap":4094842980},{"date":"2026-02-27","current":-5.738328,"twenty":-6.59852,"median":-0.642551,"eighty":-0.271707,"marketCap":2343252016},{"date":"2026-03-06","current":-5.1161,"twenty":-6.525603,"median":-0.645131,"eighty":-0.273298,"marketCap":2089164448},{"date":"2026-03-13","current":-4.454105,"twenty":-6.495818,"median":-0.656882,"eighty":-0.273627,"marketCap":1818838106},{"date":"2026-03-20","current":-4.868977,"twenty":-6.467497,"median":-0.678025,"eighty":-0.275336,"marketCap":1988251759},{"date":"2026-03-27","current":-5.23965,"twenty":-6.370491,"median":-0.694504,"eighty":-0.275763,"marketCap":2139616500},{"date":"2026-04-02","current":-5.384303,"twenty":-6.22661,"median":-0.703946,"eighty":-0.276019,"marketCap":2198685668},{"date":"2026-04-10","current":-4.777565,"twenty":-6.012578,"median":-0.718792,"eighty":-0.276332,"marketCap":1950923327},{"date":"2026-04-17","current":-4.969431,"twenty":-5.842655,"median":-0.720859,"eighty":-0.277189,"marketCap":2029272014},{"date":"2026-04-24","current":-5.087966,"twenty":-5.758444,"median":-0.724241,"eighty":-0.277697,"marketCap":2077675915},{"date":"2026-05-01","current":-5.472702,"twenty":-5.73481,"median":-0.732698,"eighty":-0.277887,"marketCap":2234783492},{"date":"2026-05-08","current":-6.830613,"twenty":-5.758444,"median":-0.740497,"eighty":-0.278585,"marketCap":2700312031},{"date":"2026-05-15","current":-6.709025,"twenty":-6.393277,"median":-0.747877,"eighty":-0.279728,"marketCap":2652245447},{"date":"2026-05-22","current":-7.366901,"twenty":-6.535065,"median":-0.752054,"eighty":-0.280426,"marketCap":2912320000},{"date":"2026-05-29","current":-8.024776,"twenty":-6.608933,"median":-0.75506,"eighty":-0.280871,"marketCap":3172394554},{"date":"2026-06-05","current":-7.224687,"twenty":-6.675155,"median":-0.757458,"eighty":-0.282109,"marketCap":2856099264},{"date":"2026-06-12","current":-6.530986,"twenty":-6.667338,"median":-0.770188,"eighty":-0.283378,"marketCap":2581862234},{"date":"2026-06-18","current":-6.453909,"twenty":-6.64758,"median":-0.774322,"eighty":-0.283727,"marketCap":2551391453},{"date":"2026-06-26","current":-7.226858,"twenty":-6.705551,"median":-0.790201,"eighty":-0.284901,"marketCap":2856957596},{"date":"2026-07-02","current":-7.394041,"twenty":-6.741593,"median":-0.791697,"eighty":-0.287059,"marketCap":2923049149},{"date":"2026-07-10","current":-8.227784,"twenty":-6.830613,"median":-0.793866,"eighty":-0.287218,"marketCap":3252648583},{"date":"2026-07-17","current":-7.811998,"twenty":-6.920316,"median":-0.805047,"eighty":-0.287691,"marketCap":3088278032},{"date":"2026-07-24","current":-7.638301,"twenty":-7.010823,"median":-0.819893,"eighty":-0.291185,"marketCap":3019611483},{"date":"2026-07-31","current":-7.722978,"twenty":-7.028862,"median":-0.830133,"eighty":-0.292962,"marketCap":3053086426},{"date":"2026-08-07","current":-7.231699,"twenty":-7.225121,"median":-0.842819,"eighty":-0.294422,"marketCap":2831839235},{"date":"2026-08-14","current":-7.783772,"twenty":-7.278539,"median":-0.870399,"eighty":-0.295212,"marketCap":3048023808},{"date":"2026-08-21","current":-8.893621,"twenty":-7.372329,"median":-0.87796,"eighty":-0.295699,"marketCap":3482626264}],"updateTime":1787584713800},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GRAL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660084498","title":"GRAIL (GRAL) Is Down 6.5% After FDA Sets Galleri PMA Panel Review – Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660084498","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660084498?lang=en_us&edition=fundamental","pubTime":"2026-08-18 21:28","pubTimestamp":1787059732,"startTime":"0","endTime":"0","summary":"GRAIL announced that the FDA’s Molecular and Clinical Genetics Panel will meet on September 23, 2026, to review the Premarket Approval application for its Galleri multi-cancer early detection blood test, which targets cancer-specific methylation patterns and is intended to complement existing screening methods.\nThis review marks a major regulatory inflection point for what GRAIL describes as the only multi-cancer early detection test backed by large interventional and randomized, controlled...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/grail-gral-is-down-65-after-fda-sets-galleri-pma-panel-revie","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/grail-gral-is-down-65-after-fda-sets-galleri-pma-panel-revie","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4129","BK4139","PMA","GRAL","BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658679762","title":"GRAIL (GRAL) Could Be 5% Overvalued As FDA Review Date Sharpens Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2658679762","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658679762?lang=en_us&edition=fundamental","pubTime":"2026-08-09 12:34","pubTimestamp":1786250074,"startTime":"0","endTime":"0","summary":"Regulatory milestone puts focus on GRAIL stock\nGRAIL (GRAL) is in the spotlight after the FDA scheduled a September 23, 2026 advisory committee meeting to review the Premarket Approval application for its Galleri multi cancer early detection blood test.\nSee our latest analysis for GRAIL.\nThe FDA panel date has come alongside GRAIL’s recent Q2 update and a sharp 1 day share price return of 9.59%, even though the year to date share price return is down 21.82%. Over the past year, the total...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/grail-gral-could-be-5-overvalued-as-fda-review-date-sharpens","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/grail-gral-could-be-5-overvalued-as-fda-review-date-sharpens","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LABU","GRAL","BK4588","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657164270","title":"GRAIL Says FDA Advisory Committee to Review GRAIL Galleri PMA Application on September 23","url":"https://stock-news.laohu8.com/highlight/detail?id=2657164270","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657164270?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:24","pubTimestamp":1786116273,"startTime":"0","endTime":"0","summary":"BRIEF-GRAIL Says FDA Advisory Committee To Review GRAIL Galleri PMA Application On September 23Aug 7 (Reuters)-GRAIL IncGRAL.O:GRAIL ANNOUNCES FDA ADVISORY COMMITTEE MEETING TO REVIEW PREMARKET APPROV","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nTUA5R0PZ1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657642458","title":"US FDA to Hold Advisory Meeting to Review Grail's Multi-Cancer Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2657642458","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657642458?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:10","pubTimestamp":1786115453,"startTime":"0","endTime":"0","summary":"US FDA to hold advisory meeting to review Grail's multi-cancer testAug 7 (Reuters)-GrailGRAL.Osaid on Friday the US FDA plans to hold a meeting of outside experts to review its multi-cancer screening test Galleri in September.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL4N4441AD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657642727","title":"Grail announces FDA advisory committee meeting to review Galleri test PMA","url":"https://stock-news.laohu8.com/highlight/detail?id=2657642727","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657642727?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:10","pubTimestamp":1786115445,"startTime":"0","endTime":"0","summary":"GRAIL (GRAL) announced that the U.S. Food and Drug Administration’s Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-announces-fda-advisory-committee-meeting-to-review-galleri-test-pma-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-announces-fda-advisory-committee-meeting-to-review-galleri-test-pma-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","BK4139","PBE","BBH","XBIX","PMA","GRAL","FBT","IBRN","BK4129","SBIO","BBP","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657642190","title":"Grail Says FDA Advisory Panel Meets Sept. 23 on Galleri Test PMA Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2657642190","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657642190?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:05","pubTimestamp":1786115129,"startTime":"0","endTime":"0","summary":"Grail says FDA advisory panel meets Sept. 23 on Galleri test PMA reviewGrail faces an FDA advisory committee review on Sept. 23, 2026 for its Galleri multi-cancer early detection blood test PMA.The PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL3BHQfs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657194642","title":"Grail Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2657194642","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657194642?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:05","pubTimestamp":1786115100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nTUA5R0PZ1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657658221","title":"Analysts Offer Insights on NA Companies: GRAIL Inc (GRAL) and Lineage, Inc. (LINE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657658221","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657658221?lang=en_us&edition=fundamental","pubTime":"2026-08-06 23:01","pubTimestamp":1786028513,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the NA sector with new ratings on GRAIL Inc (GRAL) and Lineage, Inc. (LINE). GRAIL Inc (GRAL) In a report r...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-grail-inc-gral-and-lineage-inc-line-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-grail-inc-gral-and-lineage-inc-line-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4224","BK4141","BK4139","LINE","GRAL","NA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657637857","title":"Analysts Offer Insights on NA Companies: GRAIL Inc (GRAL) and SanDisk Corp (SNDK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657637857","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657637857?lang=en_us&edition=fundamental","pubTime":"2026-08-06 21:40","pubTimestamp":1786023613,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on GRAIL Inc (GRAL) and SanDisk Corp (SNDK) with bullish sentim...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-grail-inc-gral-and-sandisk-corp-sndk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-grail-inc-gral-and-sandisk-corp-sndk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2063271972.USD","OPTZ","PTF","SNXX","TMSL","SCHA","DISK","LU0963586101.USD","SCHM","FCUS","SNDK","LU2543165471.USD","SNDC","LU2290526834.HKD","BK4139","LU0054578231.USD","QQQG","SNDG","SNDU","FSMD","GRAL","COWG","LU1861215975.USD","SNDQ","LU2360107168.USD","CNAV","BK4170","LU1861220033.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657763465","title":"Grail Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657763465","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657763465?lang=en_us&edition=fundamental","pubTime":"2026-08-06 05:01","pubTimestamp":1785963711,"startTime":"0","endTime":"0","summary":"Grail Inc reports results for the quarter ended June 30 - Earnings SummaryGrail IncGRAL.OQreported a quarterly adjusted loss of $2.56 per share for the quarter ended June 30, higher than the same quar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL8N4423HU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657520204","title":"GRAIL Q2 EPS $(2.56) Beats $(2.62) Estimate, Sales $44.687M Beat $42.760M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657520204","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657520204?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:14","pubTimestamp":1785960859,"startTime":"0","endTime":"0","summary":"GRAIL (NASDAQ:GRAL) reported quarterly losses of $(2.56) per share which beat the analyst consensus estimate of $(2.62) by 1.92 percent. This is a 19.5 percent increase over losses of $(3.18) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60970657/grail-q2-eps-2-56-beats-2-62-estimate-sales-44-687m-beat-42-760m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"GRAIL Q2 EPS $(2.56) Beats $(2.62) Estimate, Sales $44.687M Beat $42.760M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657209515","title":"Grail Q2 Revenue Rises 26%, Net Loss Narrows 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657209515","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657209515?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:11","pubTimestamp":1785960674,"startTime":"0","endTime":"0","summary":"Grail Q2 revenue rises 26%, net loss narrows 3%OverviewUS cancer screening test maker's Q2 revenue rose 26% yr/yr, Galleri test revenue up 24%Net loss for Q2 narrowed 3% from prior yearCompany complet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4421AT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOPH","BK4121","BK4139","BK4167","PSNL","GRAL","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657527632","title":"Grail Inc Q2 Net Income USD -110.247 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657527632","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657527632?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:02","pubTimestamp":1785960120,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLXJSP6G7:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656858895","title":"Grail Inc Expected to Post a Loss of $2.65 a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2656858895","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656858895?lang=en_us&edition=fundamental","pubTime":"2026-08-04 07:49","pubTimestamp":1785800949,"startTime":"0","endTime":"0","summary":"Grail Inc <GRAL.OQ> expected to post a loss of $2.65 a share - Earnings PreviewGrail IncGRAL.OQGRAL.Ois expected to  show a rise in quarterly revenue when it reports  results on August 5 for the perio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL8N4402SI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655383770","title":"Grail Management to Present at Canaccord Genuity Growth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2655383770","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655383770?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:07","pubTimestamp":1785442029,"startTime":"0","endTime":"0","summary":"Grail management to present at Canaccord Genuity Growth ConferenceGrail will present at the Canaccord Genuity 46th Annual Growth Conference in Boston on Aug. 11 at 10:00 a.m. ET.Disclaimer:This news b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDL37260p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655815418","title":"Grail to Report Q2 2026 Results After Market Close, Host Webcast Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2655815418","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655815418?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:02","pubTimestamp":1785355353,"startTime":"0","endTime":"0","summary":"Grail to report Q2 2026 results after market close, host webcast callGrail will report second-quarter 2026 financial results on Aug. 5, 2026, following the market close.Management will host a webcast,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL4whwm4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651442688","title":"Priority Health Collaborates with Grail as the First Michigan Health Plan to Offer the Galleri® Multi-cancer Early Detection Blood Test to Employer Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2651442688","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651442688?lang=en_us&edition=fundamental","pubTime":"2026-07-16 21:00","pubTimestamp":1784206805,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nTUA6NTCLX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651645285","title":"Grail Inc : Mizuho Raises Target Price to $65 from $58","url":"https://stock-news.laohu8.com/highlight/detail?id=2651645285","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651645285?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:37","pubTimestamp":1784111876,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43H0LQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650451974","title":"Cancer Blood Screen Spac's Merger is Delayed by Test's Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2650451974","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650451974?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:24","pubTimestamp":1783628640,"startTime":"0","endTime":"0","summary":"Call Thursday's cancer test results mixed.Thursday was the day set for shareholders to approve the merger of special-purpose acquisition company Perceptive Capital Solutions with cancer screening firm","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","BK4588","BK4196","LU0320765992.SGD","GH","PCSC","BK4551","BK4535","PTH","GNOM","LFSC","LU0889565916.HKD","BK4139","HELX","GRAL","LU0109394709.USD","BK4585","EKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649564670","title":"GRAIL (GRAL) Could Be 5% Overvalued Following Trial Miss And Class Actions","url":"https://stock-news.laohu8.com/highlight/detail?id=2649564670","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649564670?lang=en_us&edition=fundamental","pubTime":"2026-07-07 08:32","pubTimestamp":1783384358,"startTime":"0","endTime":"0","summary":"GRAIL (GRAL) stock has been in focus after the company disclosed that its NHS-Galleri trial did not meet the primary endpoint in reducing late stage cancers, triggering sharp losses and a wave of securities class action lawsuits.\nSee our latest analysis for GRAIL.\nSince that disclosure and the resulting securities class actions, GRAIL’s share price has seen a 14.95% 1 month share price return and a 40.28% 3 month share price return. The 1 year total shareholder return is 53.73%, suggesting...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/grail-gral-could-be-5-overvalued-following-trial-miss-and-cl","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/grail-gral-could-be-5-overvalued-following-trial-miss-and-cl","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":141,"code":"91000000","status":"200"}]}}